S-201At consideration in committee in the House of CommonsSenate Public Bill
An Act respecting a national framework on sickle cell disease
Short title: National Framework on Sickle Cell Disease Act
Sponsor:
Marie-Françoise Mégie, Senator
Proposed changes
This enactment provides for the development of a national framework to support Canadians with sickle cell disease (also known as sickle cell anemia or drepanocytosis), their families and their caregivers.
The path to law
Every bill has to clear each step, in both chambers. Tap a step's name to learn what it means.
· Senate
Completed.
May 27, 2025
· Senate
Completed.
June 12, 2025
· Senate
Completed.
Completed
· Senate
Completed.
November 18, 2025
· House of Commons
Completed.
December 11, 2025
· House of Commons
Completed.
June 16, 2026
· House of CommonsNext up
Current step.
· House of Commons
Not reached yet.
Not reached yet
· Governor General
Not reached yet.
Not reached yet
Committee study
After second reading, a examines the bill clause by clause.
Standing Senate Committee on Social Affairs, Science and Technology
(SOCI)
“Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
“Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
“Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
“Adoption of Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
“Engagement with officials on Bill S-201, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
From the Commissioner of Lobbying. A bill is listed when the lobbyist's description makes clear it means this bill, not one with the same number from another Parliament.
What MPs said
The most recent recorded speeches on this bill. Links go to the official transcript of that sitting.